+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Anaplastic Thyroid Cancer Drugs Market 2022-2026

  • PDF Icon

    Report

  • 120 Pages
  • May 2022
  • Region: Global
  • TechNavio
  • ID: 5601923
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the anaplastic thyroid cancer drugs market and it is poised to grow by $ 230.53 mn during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period. The report on the anaplastic thyroid cancer drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by high prevalence of thyroid cancer, introductions of targeted therapies, and rising geriatric population.

The anaplastic thyroid cancer drugs market analysis includes the product segment and geographic landscape.

The analyst's anaplastic thyroid cancer drugs market is segmented as below:

By Product:

  • Chemotherapy
  • Novel therapy

By Geographical Landscape:

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the growing awareness of thyroid cancer as one of the prime reasons driving the anaplastic thyroid cancer drugs market growth during the next few years. Also, strong pipeline and reimbursement policies for chemotherapy will lead to sizable demand in the market.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The report on anaplastic thyroid cancer drugs market covers the following areas:
  • Anaplastic thyroid cancer drugs market sizing
  • Anaplastic thyroid cancer drugs market forecast
  • Anaplastic thyroid cancer drugs market industry analysis

The analyst's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anaplastic thyroid cancer drugs market vendors that include Akorn Inc., Amneal Pharmaceuticals Inc., Bayer AG, Bristol Myers Squibb Co., Cipla Ltd., Daiichi Sankyo Co. Ltd., Dr. Reddys Laboratories Ltd., Eisai Co. Ltd., Exelixis Inc., Hikma Pharmaceuticals Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, Medtronic Plc, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Viatris Inc. Also, the anaplastic thyroid cancer drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Product
5.1 Market segments
Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
5.2 Comparison by Product
Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product
5.3 Chemotherapy - Market size and forecast 2021-2026
Exhibit 28: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
5.4 Novel therapy - Market size and forecast 2021-2026
Exhibit 32: Chart on Novel therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Novel therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Novel therapy - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Novel therapy - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Product
Exhibit 36: Market opportunity by Product ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Italy - Market size and forecast 2021-2026
Exhibit 62: Chart on Italy - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Italy - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Italy - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Italy - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 India - Market size and forecast 2021-2026
Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Bayer AG
Exhibit 85: Bayer AG - Overview
Exhibit 86: Bayer AG - Business segments
Exhibit 87: Bayer AG - Key offerings
Exhibit 88: Bayer AG - Segment focus
10.4 Bristol Myers Squibb Co.
Exhibit 89: Bristol Myers Squibb Co. - Overview
Exhibit 90: Bristol Myers Squibb Co. - Product / Service
Exhibit 91: Bristol Myers Squibb Co. - Key offerings
10.5 Eisai Co. Ltd.
Exhibit 92: Eisai Co. Ltd. - Overview
Exhibit 93: Eisai Co. Ltd. - Business segments
Exhibit 94: Eisai Co. Ltd. - Key offerings
Exhibit 95: Eisai Co. Ltd. - Segment focus
10.6 Johnson and Johnson
Exhibit 96: Johnson and Johnson - Overview
Exhibit 97: Johnson and Johnson - Business segments
Exhibit 98: Johnson and Johnson - Key news
Exhibit 99: Johnson and Johnson - Key offerings
Exhibit 100: Johnson and Johnson - Segment focus
10.7 Medtronic Plc
Exhibit 101: Medtronic Plc - Overview
Exhibit 102: Medtronic Plc - Business segments
Exhibit 103: Medtronic Plc - Key news
Exhibit 104: Medtronic Plc - Key offerings
Exhibit 105: Medtronic Plc - Segment focus
10.8 Merck KGaA
Exhibit 106: Merck KGaA - Overview
Exhibit 107: Merck KGaA - Business segments
Exhibit 108: Merck KGaA - Key news
Exhibit 109: Merck KGaA - Key offerings
Exhibit 110: Merck KGaA - Segment focus
10.9 Novartis AG
Exhibit 111: Novartis AG - Overview
Exhibit 112: Novartis AG - Business segments
Exhibit 113: Novartis AG - Key offerings
Exhibit 114: Novartis AG - Segment focus
10.10 Pfizer Inc.
Exhibit 115: Pfizer Inc. - Overview
Exhibit 116: Pfizer Inc. - Product / Service
Exhibit 117: Pfizer Inc. - Key news
Exhibit 118: Pfizer Inc. - Key offerings
10.11 Takeda Pharmaceutical Co. Ltd.
Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 122: Takeda Pharmaceutical Co. Ltd. - Key offerings
10.12 Viatris Inc.
Exhibit 123: Viatris Inc. - Overview
Exhibit 124: Viatris Inc. - Business segments
Exhibit 125: Viatris Inc. - Key offerings
Exhibit 126: Viatris Inc. - Segment focus
Exhibit 124:
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 127: Inclusions checklist
Exhibit 128: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 129: Currency conversion rates for US$
11.4 Research methodology
Exhibit 130: Research methodology
Exhibit 131: Validation techniques employed for market sizing
Exhibit 132: Information sources
11.5 List of abbreviations
Exhibit 133: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Product - Market share 2021-2026 (%)
Exhibits 25: Data Table on Product - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Product
Exhibits 27: Data Table on Comparison by Product
Exhibits 28: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Novel therapy - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Novel therapy - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Novel therapy - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Novel therapy - Year-over-year growth 2021-2026 (%)
Exhibits 36: Market opportunity by Product ($ million)
Exhibits 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 40: Chart on Geographic comparison
Exhibits 41: Data Table on Geographic comparison
Exhibits 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on Italy - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on Italy - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on Italy - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on Italy - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits 78: Market opportunity By Geographical Landscape ($ million)
Exhibits 79: Impact of drivers and challenges in 2021 and 2026
Exhibits 80: Overview on Criticality of inputs and Factors of differentiation
Exhibits 81: Overview on factors of disruption
Exhibits 82: Impact of key risks on business
Exhibits 83: Vendors covered
Exhibits 84: Matrix on vendor position and classification
Exhibits 85: Bayer AG - Overview
Exhibits 86: Bayer AG - Business segments
Exhibits 87: Bayer AG - Key offerings
Exhibits 88: Bayer AG - Segment focus
Exhibits 89: Bristol Myers Squibb Co. - Overview
Exhibits 90: Bristol Myers Squibb Co. - Product / Service
Exhibits 91: Bristol Myers Squibb Co. - Key offerings
Exhibits 92: Eisai Co. Ltd. - Overview
Exhibits 93: Eisai Co. Ltd. - Business segments
Exhibits 94: Eisai Co. Ltd. - Key offerings
Exhibits 95: Eisai Co. Ltd. - Segment focus
Exhibits 96: Johnson and Johnson - Overview
Exhibits 97: Johnson and Johnson - Business segments
Exhibits 98: Johnson and Johnson - Key news
Exhibits 99: Johnson and Johnson - Key offerings
Exhibits 100: Johnson and Johnson - Segment focus
Exhibits 101: Medtronic Plc - Overview
Exhibits 102: Medtronic Plc - Business segments
Exhibits 103: Medtronic Plc - Key news
Exhibits 104: Medtronic Plc - Key offerings
Exhibits 105: Medtronic Plc - Segment focus
Exhibits 106: Merck KGaA - Overview
Exhibits 107: Merck KGaA - Business segments
Exhibits 108: Merck KGaA - Key news
Exhibits 109: Merck KGaA - Key offerings
Exhibits 110: Merck KGaA - Segment focus
Exhibits 111: Novartis AG - Overview
Exhibits 112: Novartis AG - Business segments
Exhibits 113: Novartis AG - Key offerings
Exhibits 114: Novartis AG - Segment focus
Exhibits 115: Pfizer Inc. - Overview
Exhibits 116: Pfizer Inc. - Product / Service
Exhibits 117: Pfizer Inc. - Key news
Exhibits 118: Pfizer Inc. - Key offerings
Exhibits 119: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 120: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 121: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 122: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 123: Viatris Inc. - Overview
Exhibits 124: Viatris Inc. - Business segments
Exhibits 125: Viatris Inc. - Key offerings
Exhibits 126: Viatris Inc. - Segment focus
Exhibits 127: Inclusions checklist
Exhibits 128: Exclusions checklist
Exhibits 129: Currency conversion rates for US$
Exhibits 130: Research methodology
Exhibits 131: Validation techniques employed for market sizing
Exhibits 132: Information sources
Exhibits 133: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global anaplastic thyroid cancer drugs market: Akorn Inc., Amneal Pharmaceuticals Inc., Bayer AG, Bristol Myers Squibb Co., Cipla Ltd., Daiichi Sankyo Co. Ltd., Dr. Reddys Laboratories Ltd., Eisai Co. Ltd., Exelixis Inc., Hikma Pharmaceuticals Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, Medtronic Plc, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Viatris Inc.

Commenting on the report, an analyst said: "The latest trend gaining momentum in the market is growing awareness of thyroid cancer."

According to the report , one of the major drivers for this market is the high prevalence of thyroid cancer.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.


Companies Mentioned

A selection of companies mentioned in this report includes:

  • Akorn Inc.
  • Amneal Pharmaceuticals Inc.
  • Bayer AG
  • Bristol Myers Squibb Co.
  • Cipla Ltd.
  • Daiichi Sankyo Co. Ltd.
  • Dr. Reddys Laboratories Ltd.
  • Eisai Co. Ltd.
  • Exelixis Inc.
  • Hikma Pharmaceuticals Plc
  • Intas Pharmaceuticals Ltd.
  • Jo